Index DJIA, S&P 500
P/E 12.05
EPS (ttm) 6.87
Insider Own 0.09%
Shs Outstand 2.52B
Perf Week 6.08%
Market Cap 208.21B
Forward P/E 8.45
EPS next Y 9.80
Insider Trans 0.04%
Shs Float 2.51B
Perf Month -6.09%
Income 17.43B
PEG 0.99
EPS next Q 2.06
Inst Own 80.29%
Short Float 1.67%
Perf Quarter -13.41%
Sales 63.69B
P/S 3.27
EPS this Y 16.81%
Inst Trans 1.21%
Short Ratio 2.37
Perf Half Y -22.41%
Book/sh 18.32
P/B 4.52
EPS next Y 9.61%
ROA 15.30%
Short Interest 41.93M
Perf Year -34.79%
Cash/sh 5.47
P/C 15.13
EPS next 5Y 12.17%
ROE 40.81%
52W Range 75.93 - 134.63
Perf YTD -16.83%
Dividend Est. 3.29 (3.98%)
P/FCF 11.51
EPS past 5Y 12.04%
ROI 21.35%
52W High -38.54%
Beta 0.46
Dividend TTM 3.16 (3.82%)
Quick Ratio 1.15
Sales past 5Y 7.14%
Gross Margin 81.82%
52W Low 8.97%
ATR (14) 2.98
Dividend Ex-Date Mar 17, 2025
Current Ratio 1.36
EPS Y/Y TTM 4577.79%
Oper. Margin 34.72%
RSI (14) 49.07
Volatility 3.61% 3.88%
Employees 75000
Debt/Eq 0.83
Sales Y/Y TTM 4.26%
Profit Margin 27.37%
Recom 1.85
Target Price 109.63
Option/Short Yes / Yes
LT Debt/Eq 0.76
EPS Q/Q 7.20%
Payout 46.32%
Rel Volume 1.57
Prev Close 79.84
Sales Surprise 1.24%
EPS Surprise 4.09%
Sales Q/Q -1.77%
Earnings Apr 24 BMO
Avg Volume 17.73M
Price 82.74
SMA20 1.55%
SMA50 -5.23%
SMA200 -19.26%
Trades
Volume 27,768,733
Change 3.63%
Date
Action
Analyst
Rating Change
Price Target Change
Apr-22-25 Initiated
Cantor Fitzgerald
Neutral
$85
Feb-18-25 Downgrade
Deutsche Bank
Buy → Hold
$128 → $105
Feb-10-25 Downgrade
TD Cowen
Buy → Hold
$121 → $100
Jan-08-25 Downgrade
Truist
Buy → Hold
$110
Dec-20-24 Downgrade
BMO Capital Markets
Outperform → Market Perform
$136 → $105
Dec-10-24 Resumed
BofA Securities
Buy
$121
Dec-04-24 Upgrade
HSBC Securities
Hold → Buy
$130
Nov-15-24 Initiated
Wolfe Research
Peer Perform
Nov-11-24 Downgrade
Daiwa Securities
Buy → Neutral
Oct-17-24 Initiated
Bernstein
Mkt Perform
$115
Mar-11-24 Downgrade
Societe Generale
Hold → Sell
$104
Jan-04-24 Upgrade
TD Cowen
Market Perform → Outperform
$125 → $135
Nov-09-23 Initiated
Deutsche Bank
Buy
$115
Oct-27-23 Upgrade
BMO Capital Markets
Market Perform → Outperform
$132
Oct-20-23 Upgrade
UBS
Neutral → Buy
$117 → $122
Jul-14-23 Initiated
HSBC Securities
Hold
$123
Apr-13-23 Upgrade
Citigroup
Neutral → Buy
$105 → $130
Mar-28-23 Downgrade
Societe Generale
Buy → Hold
Mar-13-23 Downgrade
Wells Fargo
Overweight → Equal Weight
$120 → $115
Mar-06-23 Initiated
Jefferies
Buy
$125
Show Previous Ratings
Today 09:22AM
07:00AM
(The Wall Street Journal)
Apr-26-25 02:32PM
12:50PM
09:30AM
04:00PM
Loading…
Apr-25-25 04:00PM
11:57AM
09:25AM
06:34AM
12:49AM
(Thomson Reuters StreetEvents)
Apr-24-25 05:24PM
(The Wall Street Journal)
04:08PM
(Investor's Business Daily)
02:20PM
02:01PM
02:01PM
01:20PM
Loading…
01:20PM
12:05PM
(The Wall Street Journal)
11:22AM
10:30AM
10:19AM
(The Wall Street Journal)
09:37AM
07:43AM
07:40AM
07:07AM
06:59AM
06:40AM
(Associated Press Finance)
06:30AM
(Investor's Business Daily)
06:30AM
(Investor's Business Daily)
06:30AM
Apr-23-25 07:00PM
04:10PM
Loading…
04:10PM
(Investor's Business Daily)
02:50PM
01:08PM
09:25AM
08:02AM
Apr-22-25 09:01PM
09:06AM
07:32AM
07:09AM
07:00AM
Apr-21-25 09:33PM
11:14AM
08:17AM
Apr-20-25 05:52AM
Apr-19-25 11:44AM
11:00AM
11:00AM
11:00AM
Apr-18-25 09:00PM
10:03AM
10:00AM
09:15AM
Apr-17-25 01:13PM
01:06PM
10:01AM
09:55AM
09:00AM
Apr-16-25 04:28PM
02:41PM
01:05PM
12:56PM
09:53AM
Apr-15-25 10:43AM
09:59AM
09:09AM
07:35AM
06:54AM
Apr-14-25 05:50PM
10:37AM
10:29AM
09:08AM
05:57AM
Apr-13-25 05:57PM
02:12PM
09:15AM
Apr-11-25 12:33PM
11:15AM
Apr-10-25 12:58PM
(Investor's Business Daily) -5.32%
08:55AM
Apr-09-25 06:32PM
03:59PM
10:43AM
10:11AM
10:06AM
(Investor's Business Daily)
09:57AM
(Investor's Business Daily)
03:15AM
Apr-08-25 06:15PM
10:03AM
Apr-07-25 01:46PM
08:37AM
05:10AM
Apr-05-25 08:14AM
08:00AM
Apr-03-25 05:45PM
03:15PM
10:30AM
(The Wall Street Journal)
09:27AM
Apr-02-25 09:43AM
09:30AM
09:14AM
Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock, and companion animal species. The Other segment consists of sales for the non-reportable segments of healthcare services. The company was founded in 1891 and is headquartered in Rahway, NJ.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
DALTON SMART Officer Apr 25 '25 Proposed Sale 82.76 4,262 352,723 Apr 25 04:05 PM Oosthuizen Johannes Jacobus President, U.S. Market Feb 19 '25 Sale 84.09 8,500 714,745 30,705 Feb 20 04:01 PM JOHANNES JACOBUS OOSTHUIZEN Officer Feb 19 '25 Proposed Sale 84.09 8,500 714,745 Feb 19 05:09 PM DAVID WILLIAMS Officer Feb 13 '25 Proposed Sale 85.34 6,000 512,057 Feb 13 04:10 PM Williams David Michael EVP,Chief Info&Digital Officer Feb 13 '25 Sale 85.34 6,000 512,057 24,123 Feb 13 04:01 PM Oosthuizen Johannes Jacobus President, U.S. Market Feb 08 '25 Option Exercise 87.28 13,002 1,134,815 45,609 Feb 11 02:59 PM THULIN INGE G Director Feb 06 '25 Buy 88.25 2,833 250,000 2,933 Feb 07 04:09 PM Downing Cristal N Chief Comm. & Public Afrs Ofcr Feb 06 '25 Sale 88.76 2,361 209,551 7,085 Feb 07 04:07 PM BAKER DOUGLAS M JR Director Feb 05 '25 Buy 88.50 15,000 1,327,500 16,000 Feb 07 04:04 PM CRISTAL DOWNING Officer Feb 06 '25 Proposed Sale 88.76 2,361 209,551 Feb 06 04:43 PM Guindo Chirfi Chief Marketing Officer Aug 05 '24 Option Exercise 115.20 36,901 4,250,995 57,782 Aug 06 12:20 PM Smart Dalton SVP Fin. - Global Controller May 03 '24 Option Exercise 128.26 2,046 262,420 4,708 May 06 04:10 PM Smart Dalton SVP Fin. - Global Controller May 04 '24 Option Exercise 127.51 612 78,036 4,730 May 06 04:10 PM DeLuca Richard R. EVP&Pres, Merck Animal Heallth May 04 '24 Option Exercise 127.51 27,126 3,458,836 163,720 May 06 04:08 PM Klobuchar Michael A EVP - Chief Strategy Officer May 04 '24 Option Exercise 127.51 887 113,101 24,058 May 06 04:06 PM Oosthuizen Johannes Jacobus President, U.S. Market May 04 '24 Option Exercise 127.51 912 116,289 24,271 May 06 04:01 PM Romanelli Joseph President, Human Health Int?l May 02 '24 Option Exercise 128.80 2,262 291,346 21,831 May 02 04:29 PM Smart Dalton SVP Fin. - Global Controller May 02 '24 Option Exercise 128.80 381 49,073 3,048 May 02 04:23 PM